Applications of Oxo-Piperazin-1-Yl-Acetic Acid in Industrial Manufacturing

Oxo-Piperazin-1-Yl-Acetic Acid serves as a key intermediate in pharmaceutical and fine chemical manufacturing, offering essential functional properties that support the synthesis of active molecules and specialty polymers. Our expertise in large-scale production guarantees reliable quality and regulatory compliance for critical supply chains. Below, we detail the principal industrial application sectors, formulation parameters, processing paths, and end-use product types where this material plays a substantive role.

1. Pharmaceutical Active Pharmaceutical Ingredient (API) Synthesis

Downstream API manufacturers use Oxo-Piperazin-1-Yl-Acetic Acid as a strategic building block in the construction of complex piperazine-based drug substances. Its reactivity profile allows for precise introduction into multi-step synthetic sequences, critical in the production of CNS therapeutic APIs and certain oncology research actives. Large-scale API manufacturers require dependable quality that sustains production consistency under GMP and regulatory regimes set by global authorities.

Industry compliance standards

• EU GMP (EudraLex Vol 4, Part I & II)
• US FDA 21 CFR Part 210/211
• ICH Q7 (Guidelines for Active Pharmaceutical Ingredients)
• Ph. Eur. Monograph 0400 (where applicable)

Typical usage ratio

• 0.8%–4.2% w/w in reaction mixture; loading varies with downstream step count and molecular yield optimization

Downstream process integration

• Continuous or batchwise addition into heterocyclization or amide coupling step; used in the early-to-middle stage of multi-step synthesis pipelines for CNS and antineoplastic drug candidates

Final product types

• Active pharmaceutical ingredients (e.g., antipsychotics, neuroprotective agents)
• Precursor compounds for later-stage derivatization
• Small molecule drug research actives

2. Fine Chemical Intermediate for Agrochemical Manufacturing

Major agrochemical producers employ this raw material within multi-step syntheses aiming to create novel crop protection molecules. Its unique functional groups facilitate targeted derivatization, supporting structural complexity in the design of modern pesticides and selective herbicides. The ability to meet stringent product traceability and impurity profile requirements is critical in this field.

Industry compliance standards

• OECD Good Laboratory Practice (GLP)
• FAO/WHO Codex Alimentarius standards
• SANCO/12592/2012 (EU guidelines for plant protection product manufacture)
• ISO 9001:2015 (Quality Management System for chemical intermediates)

Typical usage ratio

• 1.0%–6.0% w/w depending on molecular target; adjusted according to reactivity and downstream conversion rates

Downstream process integration

• Introduced in the N-alkylation or heterocycle formation stages; typically enters the sequence immediately after first core assembly or as a coupling partner for piperazine scaffolds

Final product types

• Selective fungicides and insecticides
• Novel herbicide active ingredients
• Stabilized agrochemical intermediates

3. Specialty Polymer and Resin Synthesis

Leading manufacturers of high-performance polymers integrate this compound as a chain-modifying or end-capping agent to impart advanced mechanical or barrier properties. The piperazine-acetic functional group enables specific crosslinking reactions, which are fundamental in the custom development of medical-grade resins and electronics encapsulants.

Industry compliance standards

• ISO 10993-5 (Biocompatibility for medical device polymers)
• RoHS (2011/65/EU restrictions for electronic-grade plastics)
• REACH (EC No. 1907/2006 for polymer intermediates)
• UL 94 (Flammability Standard for polymer systems, where applicable)

Typical usage ratio

• 0.3%–2.0% by weight in prepolymer or post-polymerization crosslinking steps; dosing depends on targeted crosslink density and polymer application specification

Downstream process integration

• Added directly to the monomer blend during pre-polymerization, or as a reactive diluent during melt mixing or solution processing; used in formulations where controlled reactivity is essential for final material properties

Final product types

• Medical device housings (requiring precise biocompatibility)
• High-barrier packaging films and coatings
• Encapsulant resins for electronics and optoelectronics

4. Intermediate for Diagnostic Reagent Synthesis

Producers of clinical and analytical reagents rely on Oxo-Piperazin-1-Yl-Acetic Acid for constructing targeted linker segments and labeling moieties. These components require advanced purity control to ensure accuracy and reliability in diagnostic kits and laboratory assay platforms, particularly for high-sensitivity biomarker detection chemistries.

Industry compliance standards

• ISO 13485:2016 (Quality Management System for medical diagnostics)
• US FDA 21 CFR Part 820 (Medical Device Quality System Regulation)
• CLSI GP42 (Clinical laboratory reagent manufacturing guidelines)
• cGMP for Diagnostic Reagents

Typical usage ratio

• 0.2%–1.6% w/w; exact concentration tailored to the conjugation chemistry and sensitivity demands of the detection system

Downstream process integration

• Formulated into synthetic linker or labeling steps—usually as an amide coupling or as a bridge for attaching small-molecule labels to antibodies or oligonucleotides in one-pot or sequential reactions

Final product types

• In vitro diagnostic antibodies and kits (ELISA, immunoassays)
• Specialty analytical reagents for clinical laboratory use
• Labeled biochemical probes